Elaine Zhang - Covalon Technologies VP Operations
| CVALF Stock | USD 2.62 0.14 5.65% |
Insider
Elaine Zhang is VP Operations of Covalon Technologies
| Phone | 905 568 8400 |
| Web | https://www.covalon.com |
Covalon Technologies Management Efficiency
The company has return on total asset (ROA) of (0.161) % which means that it has lost $0.161 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.3213) %, meaning that it generated substantial loss on money invested by shareholders. Covalon Technologies' management efficiency ratios could be used to measure how well Covalon Technologies manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 13 records | INSIDER Age | ||
| Dr MBA | Cellectis SA | 46 | |
| Jay Carlson | Mosaic Immunoengineering | N/A | |
| Steven King | Mosaic Immunoengineering | 59 | |
| Pascalyne Wilson | Cellectis SA | N/A | |
| Paul CPA | Mosaic Immunoengineering | 55 | |
| Valerie Cros | Cellectis SA | N/A | |
| Cyril Empig | Mosaic Immunoengineering | N/A | |
| Kyung NamWortman | Cellectis SA | 53 | |
| MSc MSc | Cellectis SA | 54 | |
| Joseph MPH | Mosaic Immunoengineering | 50 | |
| Jean Epinat | Cellectis SA | N/A | |
| Marvin MD | Mosaic Immunoengineering | 79 | |
| Nicole Steinmetz | Mosaic Immunoengineering | 43 | |
Management Performance
| Return On Equity | -0.32 | |||
| Return On Asset | -0.16 |
Covalon Technologies Leadership Team
Elected by the shareholders, the Covalon Technologies' board of directors comprises two types of representatives: Covalon Technologies inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Covalon. The board's role is to monitor Covalon Technologies' management team and ensure that shareholders' interests are well served. Covalon Technologies' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Covalon Technologies' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Valerio DiTizio, Co-Founder and Chief Science Officer | ||
| Simon Smith, Chief Ltd | ||
| Brian Pedlar, CEO and President and Director | ||
| Ron Hebert, VP Marketing | ||
| Greg Leszczynski, VP HR | ||
| Hamed Abbasian, VP Devel | ||
| Gerry Arambula, Pres Ltd | ||
| Jason Gorel, Interim Officer | ||
| Elaine Zhang, VP Operations | ||
| Mark Doolittle, VP Sales |
Covalon Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Covalon Technologies a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.32 | |||
| Return On Asset | -0.16 | |||
| Profit Margin | (0.53) % | |||
| Operating Margin | (0.50) % | |||
| Current Valuation | 35.37 M | |||
| Shares Outstanding | 25.07 M | |||
| Shares Owned By Insiders | 56.60 % | |||
| Price To Earning | 37.95 X | |||
| Price To Book | 2.12 X | |||
| Price To Sales | 2.30 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Covalon OTC Stock
Covalon Technologies financial ratios help investors to determine whether Covalon OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Covalon with respect to the benefits of owning Covalon Technologies security.